Skip to main content

Two Ontario Labs Adopt Tm Bio's Respiratory Viral Panel

NEW YORK (GenomeWeb News) - Tm Bioscience today said two labs in Ontario are using its ID-TAG Respiratory Viral Panel to detect acute respiratory pathogens.
 
The company said St. Joseph's Healthcare in Hamilton, Ontario, and London Health Sciences Center, in London, Ontario, are using its RVP, which is designed to detect "the majority of strains and subtypes of respiratory viruses" including those that cause influenza strains A and B.
 
Tm Bio's president and CEO, Greg Hines, said the deals reflect "the growing recognition of the value of our approach to infectious disease testing."
 
Jim Mahony, a lab director at St. Joseph's, said the RVP test "rapidly detects and identifies specific pathogens from a long list of potential respiratory viruses," which doctors can use to determine treatment methods.
 
Financial terms of the agreements were not disclosed.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.